20th Annual NAPPSA Scientific Conference & Exposition
Faculty & Speakers
September 17–20, 2026 | Hyatt Regency Aurora-Denver Conference Center | Aurora, Colorado
Faculty & Speakers
Speakers
Listed alphabetically by last name. Credentials, title, institution, and location are as submitted; entries marked “location not yet confirmed” will be updated as information is received.
Samuel O. Adekola, FPSN, FNAPharm, IION
Senior Consultant, Ondo State Government; Program Director, ACPN-TGPDF — Ondo State, Nigeria
Olu Aloba, PhD, RPh
Vice President, CMC Services, Premier Research — Morrisville, NC, USA
Jessica Angleson, PharmD, MBA, BCPS
Managing Network Facilitator, CPESN Colorado; Pharmacy Practice Advancement Lead, CPS — Colorado, USA
Okezie Aruoma, MBA, PhD, DSc, FRSC
President/CEO, Global PharmHealth Investors Inc.; Professor, California State University — Los Angeles, California, USA
His Highness Ambassador Ahmad Nuhu Bamalli, CFR, LLD
the Emir of Zazzau; Chairman, Kaduna State Council of Chiefs — Kaduna State, Nigeria
Ifeanyi Egbunike-Chukwuma, PharmD, BCPS
Director of Pharmacy Services, Luminis Health Doctors Community Medical Center — Lanham, MD, USA
Charles Okechukwu Esimone, FAS, FPSN, FNAPharm
Pro-Chancellor, European University of Nigeria — Anambra State, Nigeria
Bankole Aminu Ezebuilo, FPSN, MD
CEO, Kayhelt Pharma; Industrial Pharmacist Chairman of Nigeria — Lagos, Nigeria
Lisa Faast, PharmD
CEO, DiversifyRx — Southlake, Texas, USA
Meredith A. Hawkins, MD
Professor, Albert Einstein College of Medicine — Bronx, New York, USA
Kenneth Izuora, MD, MBA, FACE
Professor & Director, Endocrinology Fellowship Program, University of Nevada Las Vegas School of Medicine — Las Vegas, Nevada, USA
Nkem P. Nonyel, PharmD, MPH, BCPS
Associate Professor, Howard University College of Pharmacy — Washington, DC, USA
Jude Nwokike, PhD, MSc, MPH, BPharm
CEO, EALI Access LLC — Rockville, MD, USA
J. Valentine Okelu, FPSN
Managing Director/CEO, Neimeth International Pharmaceuticals PLC — Lagos, Nigeria
Oluyinka Olutoye, MD, PhD — Keynote Speaker
Surgeon-in-Chief, Nationwide Children’s Hospital — Columbus, Ohio, USA
Nonye Onyewuenyi, PhD
CEO & Chief Scientific Officer, Noniks Analytics — Lawrenceville, NJ, USA
Prof. Azuka C. Oparah
Department of Clinical Pharmacy, University of Benin — Benin City, Nigeria
Todd Raehtz, MBA, MSPA, BPharm
CEO and President, Indispensable Health — Grass Lake, MI, USA
Jane E.B. Reusch, MD
Professor, University of Colorado School of Medicine — Aurora, Colorado, USA
Chidebelu Ufodike, PharmD
Chief Operating Officer, Carnavio Inc — Cherry Hill, NJ, USA
Anayo M. Ukeje, PhD, DIC
Associate Director, Global Pharmaceutical Technology, Product Development, Science & Technology, AbbVie Inc. — Skokie, Illinois, USA
Charlotte Wagner, PharmD, BCOP
Assistant Professor, Oncology Pharmacy, University of Colorado Skaggs School of Pharmacy — Aurora, Colorado, USA
Moderators & Panelists
Named individuals serving as session moderators or panelists (not presenting an individually numbered session). Sessions without a named moderator below are marked “To be announced” on the conference schedule and will be updated as assignments are confirmed.
Ibrahim Babashehu Ahmed, Pharm.
Registrar, Pharmacy Council of Nigeria (PCN) — Abuja, Nigeria — Panelist, Session #100
Akin Akinseye, RPh, PSM, CSPO
Creative Director, SlimionRx — location not yet confirmed — Panelist, Session #700 Q&A
Olu Aloba, PhD, RPh
Vice President, CMC Services, Premier Research — Morrisville, NC, USA — Speaker, Session #301 & Moderator, Session #200 Q&A
Okezie Aruoma, MBA, PhD, DSc, FRSC
President/CEO, Global PharmHealth Investors Inc.; Professor, California State University — Los Angeles, California, USA — Panelist, Session #300 Q&A
Nedra Chijioke, PharmD, RPh
Medical Science Liaison, Takeda Pharmaceuticals — Chicago, IL, USA — Panelist, Session #500
Felix Egbase, RPh
CEO, Aaron Pharmacy Inc. — Las Vegas, Nevada, USA — Moderator, Session #700 Q&A
Obinna Ego, MD, FHM, FAAP, FACP
President/Founder, Zion Medical Group — Gilbert, Arizona, USA — Panelist, Session #100 Panel Discussion (Thursday)
Toluleke Famuyiwa, PhD
Postdoctoral Research and Clinical Fellow, National Institutes of Health — Frederick, MD, USA — Panelist, Session #500
Emilia Iwu, PhD, RN, APNC, FWACN, FAAN
Assistant Dean, Center for Global Health, School of Nursing — Atco, NJ, USA — Panelist, Session #100
Gerald Muforo, PharmD
Walmart Pharmacy — Tampa, Florida, USA — Moderator, Session #300 Q&A & Session #600 Panel Discussion
Glory Uzunma Nosike, PharmD
CEO, Choice Pharmacy — Houston, TX, USA — Moderator, Session #800B
Patrick Nwakama, PharmD, BCPS
Senior Pharmacologist, US Food and Drug Administration — Silver Spring, Maryland, USA — Moderator, Session #800A
Nonye Nwaneri-Iwuchukwu, PharmD, BCOP
Oncology Pharmacist, Harris Health — Houston, Texas, USA — Moderator, Session #800B
Juliet Obi, PhD
Advisor, Biophysical Chemistry, Eli Lilly and Company — San Diego, CA, USA — Moderator, Sessions #100 & #500
Theresa Ofili, PharmD, MPH, BS Pharm, RN
Instructional Assistant Professor of Pharmacy Practice, Texas A&M University College of Pharmacy — College Station, TX, USA — Moderator, Panel Discussion (Thursday)
Precious Okeke, PharmD, RPh, MSc
Assistant Professor of Pharmaceutical Sciences, Texas A&M College of Pharmacy — San Antonio, TX, USA — Panelist, Session #500
Chinyere Onyebuchi, PhD, PMP
VP, Head of Oncology Portfolio Strategy and Operations, Takeda Pharmaceuticals — Cambridge, MA, USA — Panelist, Session #500
Kunle Tometi, PharmD, FNAPPSA
President, NAPPSA Inc. — Dallas, TX, USA — Welcome Address (Thursday) & Opening Ceremony (Friday)
Professor Cyril Usifoh
Department of Pharmaceutical Chemistry, University of Benin (PSN) — Benin City, Nigeria — Panelist, Session #100
Faculty information is posted as received and will be updated as additional assignments, credentials, and locations are confirmed. For corrections, contact nappsa@nappsa.org.